icap and hybio pharmaceutical invest in japan fuji yakuhin on gout medicine project -买球的app排行榜

on november 8th, icap and its shareholder hybio (300199) collaborated with the japanese company fuji yakuhin on a gout medicine project.

 

zeng shaogui, chairman of hybio(front row, first from left), takayanagi masayuki, president of fuji pharmaceutical(first right, first from right) and song siyun, board member, vice general manager of icap (back row, third from left,) signed the contract in shenzhen.